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mmunoglobulin-like Necl-5/Tage4/poliovirus recep-
tor (PVR)/CD155, originally identiﬁed as the PVR,
has been shown to be up-regulated in cancer cells
and to enhance growth factor–induced cell movement
and proliferation. In addition, Necl-5 heterophilically
trans-interacts with nectin-3, a cell–cell adhesion mole-
cule known to form adherens junctions in cooperation
with cadherin. We show here that Necl-5 was down-
regulated from cell surface upon cell–cell contacts in
I
 
NIH3T3 cells. This down-regulation of Necl-5 was initi-
ated by its interaction with nectin-3 and was mainly
mediated by clathrin-dependent endocytosis. Then, the
down-regulation of Necl-5 induced in this way reduced
movement and proliferation of NIH3T3 cells. These results
indicate that the down-regulation of Necl-5 induced by
its interaction with nectin-3 upon cell–cell contacts may
be at least one mechanism underlying contact inhibition
of cell movement and proliferation.
 
Introduction
 
Necl-5/Tage4/poliovirus receptor (PVR)/CD155 is an emerg-
ing molecule that regulates cell movement and proliferation
(Ikeda et al., 2004; Kakunaga et al., 2004). Human PVR/
CD155 was originally identified as human PVR (Mendelsohn
et al., 1989; Koike et al., 1990), whereas rodent Tage4 was
originally identified as the product of a gene overexpressed in
rodent colon carcinoma (Chadeneau et al., 1994, 1996). PVR/
CD155 was subsequently shown to be overexpressed in many
human cancer cells (Gromeier et al., 2000; Masson et al.,
2001; Sloan et al., 2004). Necl-5 is one member of the nectin-
like molecule family, which consists of five members—Necl-1,
-2, -3, -4, and -5 (Takai et al., 2003). Nectin-like molecules
have been named for a group of Ig-like molecules with domain
structures that are similar to, but slightly different from, those
of nectins. Nectins are Ca
 
2
 
 
 
-independent Ig-like cell–cell ad-
hesion molecules that constitute a family consisting of four
members—nectin-1, -2, -3, and -4 (Takai and Nakanishi,
2003; Takai et al., 2003). Nectins form cis-dimers, followed
by formation of trans-dimers (trans-interaction), eventually
causing cell–cell adhesion. Nectins recruit cadherins to the
nectin-based cell–cell adhesion sites to cooperatively form ad-
herens junctions in epithelial cells and fibroblasts. In contrast
to nectins, Necl-5 does not show homophilic cell–cell adhe-
sion activity (Aoki et al., 1997; Ikeda et al., 2003). Nectins are
associated with the actin cytoskeleton through afadin, a nectin-
and actin-filament–binding protein, but Necl-5 does not bind
afadin (Ikeda et al., 2003; Takai and Nakanishi, 2003; Takai
et al., 2003).
Although the role of Necl-5 as PVR has been established,
its physiological role remained unknown for a long time. We
recently found that Necl-5 is functionally associated with in-
tegrin 
 
 
 
V
 
 
 
3
 
 at leading edges of moving cells, such as L cells
stably expressing Necl-5 and NIH3T3 cells transformed by an
oncogenic Ki-Ras (V12Ras-NIH3T3 cells), and enhances the
movement induced by growth factors, such as PDGF, in an
integrin-dependent manner in NIH3T3 cells (Ikeda et al.,
2004). Necl-5 enhances the growth factor–induced activation
of Cdc42 and Rac, causing the formation of filopodia and
lamellipodia, respectively, which eventually enhances cell
movement. The cytoplasmic region of Necl-5 binds Tctex-1, a
subunit of the dynein motor complex, which may be also in-
volved in regulation of the cell movement in cooperation with
microtubules (Mueller et al., 2002). Necl-5 enhances not only
the cell movement but also the proliferation induced by growth
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factors, such as PDGF and FGF, in NIH3T3 cells (Kakunaga et
al., 2004). Necl-5 enhances the activation of the Ras–Raf–
MEK–ERK signaling and causes up- and down-regulation of
the cell cycle regulators, including cyclins D2 and E and
p27
 
kip1
 
, thereby shortening the period of the G
 
1
 
 phase of cell
cycle. Necl-5 is up-regulated in V12Ras-NIH3T3 cells, and
this up-regulation is mediated by the transcriptional activation
of the 
 
Necl-5
 
 gene through the V12Ras–Raf–MEK–ERK–AP-1
pathway (Hirota et al., 2005). On the other hand, it has been
shown that Necl-5 heterophilically trans-interacts with nectin-3
(Ikeda et al., 2003; Mueller and Wimmer, 2003), but the phys-
iological function of the interaction of Necl-5 with nectin-3
remains unknown.
We describe here that the cell–cell contact-induced inter-
action of Necl-5 with nectin-3 causes the endocytosis-mediated
down-regulation of Necl-5 from the cell surface, resulting in
reduction of cell movement and proliferation.
 
Results
 
Cell density–dependent down-regulation 
of Necl-5
 
NIH3T3 cells were starved for 24 h and cultured in the pres-
ence of serum. The cells continued to proliferate until they be-
came confluent (Fig. 1 A, a, closed blue squares). At various
periods of time, the cell surface proteins containing Necl-5
were labeled with biotin and the amount of cell surface Necl-5
was measured. The amount of cell surface Necl-5 gradually de-
creased as cell density increased (Fig. 1 A, a [closed red circles]
and b), whereas the amount of cell surface nectin-1, nectin-3, or
N-cadherin did not change. Expression of nectin-2, Necl-1, or
Necl-2 was not detected by Western blotting in NIH3T3 cells
(Shingai et al., 2003; unpublished data). When NIH3T3 cells
were cultured at two different cell densities for 24 h, the
amount of cell surface Necl-5 decreased in the cells cultured at
Figure 1. Cell density–dependent down-
regulation of Necl-5. (A) Cell density–dependent
down-regulation of Necl-5. NIH3T3 cells were
seeded, starved of serum, and cultured in the
medium containing serum in the presence or
absence of the anti–Necl-5 mAb-i. The cells
were sampled at each indicated time. (a) Cell
growth curves, amounts of cell surface Necl-5,
and levels of Necl-5 mRNA. The relative
amounts of cell surface Necl-5 and the level of
Necl-5 mRNA at 0 h were set to 1. (b) West-
ern blotting of cell surface proteins. Biotinyl-
ated cell surface proteins were subjected to
SDS-PAGE (10% polyacrylamide gel), fol-
lowed by Western blotting with the anti–Necl-5
pAb, the anti–nectin-1 pAb, the anti–nectin-3
pAb, or the anti–N-cadherin mAb. (B–E)
Down-regulation of Necl-5 in the cells cultured
at the higher density. NIH3T3 cells were cul-
tured at the lower or higher density for 24 h.
(B) Western blotting of cell surface proteins in
the absence or presence of the anti–Necl-5
mAb-i. Biotinylated cell surface proteins were
subjected to SDS-PAGE (10% polyacrylamide
gel), followed by Western blotting with the
anti–Necl-5 pAb, the anti–nectin-1 pAb, the
anti–nectin-3 pAb, or the anti–N-cadherin
mAb. (C) FACS analysis of cell surface Necl-5.
The cells were stained with the anti–Necl-5
mAb-i. (D) Immunofluorescence images. The
cells were double stained with various combi-
nations of the anti–Necl-5 mAb-i, the anti–
nectin-3 mAb, the anti–N-cadherin pAb, and
the antiactin mAb. Bars, 10  m. (E) The levels
of Necl-5 mRNA. The level of Necl-5 mRNA at
the lower cell density was set to 1. The results
shown in A and E are the mean   SEM of the
three independent experiments, and the results
shown in B, C, and D are representative of
three independent experiments. 
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a higher density as compared with that in the cells cultured at a
lower density (Fig. 1 B), whereas the amount of cell surface
nectin-1, nectin-3, or N-cadherin did not change at these differ-
ent cell densities. Similar results were obtained by FACS anal-
ysis (Fig. 1 C). The immunofluorescence signal for Necl-5 was
concentrated presumably at the leading edges of the cells cul-
tured at the lower density (Fig. 1 D, a1–a3). The signal for
nectin-3 did not concentrate anywhere (Fig. 1 D, b1–b3). The
signal for N-cadherin was mainly detected at the cytoplasmic
and perinuclear regions and slightly detected at the entire
plasma membrane (Fig. 1 D, c1–c3). When the cells were cul-
tured at the higher density, the signals for nectin-3 and N-cad-
herin were concentrated at the cell–cell contact sites (Fig. 1 D,
d2, d3, and e1–e3), but the signal for Necl-5 was hardly de-
tected there (Fig. 1 D, d1 and d3). These results indicate that
Necl-5 is down-regulated in a cell density–dependent manner.
We observed the similar down-regulation of Necl-5 in other
cell lines, including Swiss3T3 cells (unpublished data) and
mouse embryonic fibroblasts (MEFs; Fig. S1, available at http:
//www.jcb.org/cgi/content/full/jcb.200501090/DC1).
 
Down-regulation of Necl-5 by its 
interaction with nectin-3
 
We next examined how this cell density–dependent down-regu-
lation of Necl-5 is induced in NIH3T3 cells. Necl-5 does not ho-
mophilically trans-interact, but heterophilically trans-interacts
with nectin-3 (Aoki et al., 1997; Ikeda et al., 2003; Mueller and
Wimmer, 2003). Therefore, one possible mechanism is that the
cell density–dependent interaction of Necl-5 with nectin-3 trig-
gers the down-regulation of Necl-5. To examine this possibility,
we used an mAb against the extracellular region of Necl-5
(mAb-i) known to inhibit the trans-interaction of Necl-5 with
nectin-3 (Ikeda et al., 2003). NIH3T3 cells were starved for 24 h
and cultured in the presence of serum and this mAb-i. The cell
density–dependent down-regulation of cell surface Necl-5 was
markedly inhibited by the mAb-i (Fig. 1 A, a [open red circles]
and b). When NIH3T3 cells were cultured at the two different
cell densities for 24 h in the presence of the mAb-i, the down-reg-
ulation of cell surface Necl-5 at the higher density was inhibited
(Fig. 1 B). These results suggest that the interaction of Necl-5
with nectin-3 is required for the down-regulation of Necl-5.
We then performed knockdown of nectin-3 using the
small interfering RNA (siRNA) method. Transfection of the
synthetic siRNA against nectin-3 reduced the total amount of
nectin-3 as estimated by Western blotting (Fig. 2 A, a). The to-
tal amount of nectin-1 or N-cadherin did not change (unpub-
lished data). The amount of cell surface nectin-3, but not that of
nectin-1 or N-cadherin, similarly decreased (Fig. 2 B, a). Im-
munofluorescence microscopy also showed that the signal for
nectin-3 markedly decreased (Fig. 2 A, b1–c2). The signal for
N-cadherin did not change, which might be attributable to the
presence of nectin-1. When the nectin-3 knockdown cells were
cultured at the lower or higher density, the down-regulation of
cell surface Necl-5 at the higher density markedly decreased as
estimated by Western blotting (Fig. 2 B, a). Immunofluores-
cence microscopy showed that the cell surface signal for Necl-5
did not decrease in the nectin-3 knockdown cells cultured at the
higher density (Fig. 2 B, b1–c2). These results indicate that
nectin-3 is a major molecule trans-interacting with Necl-5 and
induces its down-regulation.
We further confirmed this conclusion by another method
using the recombinant protein of the extracellular fragment of
nectin-3 fused to human IgG Fc portion (Nef-3), which interacts
with cellular Necl-5 as well as nectin-1 and -3 (Honda et al.,
2003; Sato et al., 2004). When NIH3T3 cells were incubated
with Nef-3, Nef-3 reduced the cell surface signal for Necl-5 at
the leading edges of the cells (Fig. 3 A, a [arrowheads] and b1),
whereas Nef-1 did not do that for Necl-5 (Fig. 3 A, C, arrow-
heads). Nef-1 is the recombinant protein of the extracellular
fragment of nectin-1, fused to human IgG Fc portion and inter-
Figure 2. Reduction of the down-regulation of Necl-5 by
knockdown of nectin-3. NIH3T3 cells were transfected with
the synthetic siRNA against nectin-3 or the control synthetic
siRNA and cultured for 48 h. The transfection efficiency was
 90%. (A) Confirmation of the knockdown of nectin-3. (a)
Western blotting. The cell lysates were subjected to SDS-PAGE
(10% polyacrylamide gel), followed by Western blotting with
the anti–nectin-3 pAb. (b and c) Immunofluorescence im-
ages. The cells were double stained with the anti–nectin-3
mAb and the anti–N-cadherin pAb. (b) Control; (c) nectin-3
siRNA. Bars, 10  m. (B) Reduction of the down-regulation
of Necl-5 by knockdown of nectin-3. The siRNA-transfected
cells were cultured at the lower or higher density. (a) West-
ern blotting of cell surface proteins. Biotinylated cell surface
proteins were subjected to SDS-PAGE (10% polyacrylamide
gel), followed by Western blotting with the anti–Necl-5 mAb-i,
the anti–nectin-1 pAb, the anti–nectin-3 pAb, or the anti–
N-cadherin mAb. (b and c) Immunofluorescence images. The
cells were double stained with the anti–Necl-5 mAb-i and the
anti–nectin-3 pAb. (b) Control; (c) nectin-3 siRNA. Bars, 10
 m. The results shown are representative of three indepen-
dent experiments. 
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acts with nectin-1 and -3, but not with Necl-5 (Honda et al.,
2003; Ikeda et al., 2003). The activity of Nef-3 was blocked by
the anti–Necl-5 mAb-i (Fig. 3 A, d, arrowheads). The activity of
Nef-3 was also blocked by Nef-1, which is known to interact
with not only cellular nectin-1 and -3 but also Nef-3 (Honda et
al., 2003; Ikeda et al., 2003; Fig. 3 A, e, arrowheads). The Nef-3–
induced down-regulation of cell surface Necl-5 was confirmed
by Western blotting and FACS analysis (Fig. 3, B and C).
This effect of Nef-3 was dose dependent, and the minimum
concentration of Nef-3 necessary for this effect was 
 
 
 
7 nM.
Together, these three lines of evidence indicate that the cell
density–dependent down-regulation of Necl-5 is induced by
the interaction of Necl-5 mainly with nectin-3.
 
Down-regulation of Necl-5 through 
endocytosis
 
The down-regulation of Necl-5 from the cell surface might be
the result of its endocytosis, reduction of de novo synthesis, or
both. When NIH3T3 cells were incubated with Nef-3, Nef-3
not only reduced the cell surface immunofluorescence signal
for Necl-5 but also increased the spotlike signal for Necl-5 in-
side the cells (Fig. 3 A, b1). This Nef-3–induced spotlike intra-
cellular signal for Necl-5 was inhibited by the anti–Necl-5
mAb-i and Nef-1 (Fig. 3 A, d and e). The spotlike signal for
Necl-5 was not observed in the presence of Nef-1 (Fig. 3 A, c).
When Necl-5 was stained without permeabilization of the cell
to detect only cell surface Necl-5, the intracellular signal for
Necl-5 was not detected (Fig. 3 A, f). The spotlike intracellular
signal for Necl-5 mostly coincided with the signal for Rab7, a
marker for the late endosome (Fig. 3 A, g1–g3; Feng et al.,
1995), suggesting that endocytosed Necl-5 is transported to the
late endosome. The signal for Nef-3 colocalized with the spot-
like signal for Necl-5 (Fig. 3 A, b1–b3). This Nef-3 was likely
to interact with Necl-5 and to be coendocytosed with Necl-5.
Western blotting and FACS analyses showed that Nef-3 not
only reduced the amount of cell surface Necl-5 (Fig. 3, B and C)
but also increased the amount of endocytosed Necl-5 (Fig. 3 D).
These results suggest that the down-regulation of Necl-5 is at
least partly attributable to its endocytosis.
We then measured 
 
Necl-5
 
 mRNA levels. Although the
 
Necl-5
 
 mRNA levels showed no obvious difference between
the cells cultured at the lower and higher densities for 24 h
(Fig. 1 E), they gradually decreased in a cell density–dependent
manner when they were cultured for longer periods of time
(Fig. 1 A, a, closed orange triangles). These results suggest that
the cell density–dependent down-regulation of Necl-5 at the
early stage is mainly mediated by endocytosis, although its
down-regulation at the late stage is mediated by both endocyto-
sis and transcriptional inactivation of the 
 
Necl-5
 
 gene.
 
Clathrin-dependent endocytosis of Necl-5
 
There are at least two types of endocytosis: clathrin-dependent
and -independent ones (Conner and Schmid, 2003). Epsin and
Eps15 are regulatory components of the formation of clathrin-
coated vesicles (Conner and Schmid, 2003), and the ENTH
(epsin NH
 
2
 
-terminal homology domain) and the DIII domain of
Eps15 act as dominant-negative (DN) mutants for the clathrin-
dependent endocytosis (Benmerah et al., 1998; Nakashima et
al., 1999). Dynamin is an important regulator for the formation
of both clathrin-dependent and -independent endocytic vesi-
cles, and its DN mutant, dynamin1 K44A, inhibits various
types of endocytosis (Conner and Schmid, 2003). Caveolin
regulates the formation of caveolae and its endocytosis, and an
NH
 
2
 
-terminal–truncated mutant of caveolin, DGV-caveolin,
serves as a DN mutant and inhibits the formation of caveolae
by perturbing intracellular cholesterol trafficking (Conner and
Schmid, 2003). To test whether or not the endocytosis of Necl-5
depends on clathrin, various DN mutants were expressed in
Figure 3. Down-regulation of Necl-5 by its interaction with nectin-3.
NIH3T3 cells were cultured at the lower density in the absence or pres-
ence of Nef-3, other recombinant proteins, and/or mAb for 1 h. (A) Immuno-
fluorescence images. The cells were single or double stained with various
combinations of the anti–Necl-5 mAb-i, the rhodamine-conjugated anti–
human IgG Fc pAb, and the anti-Rab7 pAb. (a) Control; (b, f, and g) in
the presence of 0.3  M Nef-3; (c) in the presence of 0.3  M Nef-1; (d) in
the presence of 0.3  M Nef-3 and 50  g/ml of the anti–Necl-5 mAb-i; (e)
in the presence of 0.3  M Nef-3 and Nef-1. (a–e and g) Immunostaining
with permeabilization; (f) immunostaining without permeabilization. Arrow-
heads show the signal for Necl-5 at the leading edges of the cells. Bars,
10  m. (B) Western blotting of cell surface proteins in the absence or pres-
ence of 0.3  M Nef-3. Biotinylated cell surface proteins were subjected to
SDS-PAGE (10% polyacrylamide gel), followed by Western blotting with
the anti–Necl-5 pAb or the anti–N-cadherin mAb. (C) FACS analysis of
cell surface Necl-5 in the absence or presence of 0.3  M Nef-3. The cells
were fixed with 1% formaldehyde before FACS analysis and stained with
the anti–Necl-5 mAb-i. (D) Western blotting of endocytosed Necl-5 in the
absence or presence of 0.3  M Nef-3. Necl-5, which was biotinylated
and endocytosed, was subjected to SDS-PAGE (10% polyacrylamide gel),
followed by Western blotting with the anti–Necl-5 pAb. The results shown
are representative of three independent experiments. 
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NIH3T3 cells, and the cells were plated and cultured at the
higher density. The nectin-3–induced decrease of the cell sur-
face signal for Necl-5 was inhibited by the expression of the
myc-tagged epsin DN mutant (Fig. 4 A, a1–a4, asterisks). The
signal for nectin-3 did not change. The essentially similar re-
sults were obtained by the expression of the EGFP-tagged
Eps15 DN mutant or HA-tagged dynamin DN mutant (Fig. 4 A,
b1–c4, asterisks). The nectin-3–induced decrease of the cell
surface signal for Necl-5 was not affected by the expression of
the EGFP-tagged caveolin DN mutant (Fig. 4 A, d1–d4, aster-
isks). These results indicate that Necl-5 is down-regulated by
the clathrin-dependent endocytosis.
We next examined how the interaction of Necl-5 with
nectin-3 induces the clathrin-dependent endocytosis of Necl-5.
Microbeads coated with Nef-3 were put on the surface of
NIH3T3 cells cultured at the lower density and incubated for
1 h. The beads coated with IgG were used as a control. The
signals for Necl-5 and clathrin heavy chain colocalized at the
contact sites between the Nef-3–coated beads and NIH3T3
cells (Fig. 4 B, a1–a3) but not between the IgG-coated beads
and the cells (Fig. 4 B, b1–b3). The essentially similar results
were obtained when adaptin 
 
 
 
, a component of adaptor pro-
tein complex AP2, which is involved in the formation of
endocytotic clathrin-coated vesicles (Conner and Schmid,
2003), was stained instead of clathrin heavy chain (unpub-
lished data). In the absence of the beads, the signal for Necl-5
was concentrated presumably at the leading edges, whereas
the signal for clathrin heavy chain was detected as the spot-
like signals at the cytoplasmic and perinuclear regions and
did not colocalize with that for Necl-5 (Fig. 4 B, c1–c3).
These results suggest that the interaction of Necl-5 with nectin-3
induces the assembly of the components necessary for the
formation of the endocytotic clathrin-coated vesicles at the
cytoplasmic region of Necl-5, eventually leading to the en-
docytosis of Necl-5.
 
Reduction of cell movement and 
proliferation by the down-regulation of 
Necl-5
 
We next examined the effect of the down-regulation of Necl-5
on cell movement and proliferation. NIH3T3 cells, which
were cultured at the lower or higher density in the presence or
absence of the anti–Necl-5 mAb-i, were replated, and cell
movement after 9 h was assayed by the Boyden chamber
method. In the absence of this mAb-i, the amount of cell sur-
face Necl-5 and the degree of movement of NIH3T3 cells pre-
cultured at the higher density decreased in a roughly parallel
manner as compared with those of the cells precultured at the
lower density (Fig. 5 A, a and b). The decreases of these pa-
rameters were blocked by the mAb-i (Fig. 5 A, a and b). The
level of Necl-5 down-regulated in the cells cultured at the
higher density did not return to the original level at 9 h after
replating at the lower density, but returned to the original
level at 24 h (Fig. 5 A, b; and not depicted). The cells were
cultured at the lower or higher density in the presence or ab-
sence of the mAb-i, and DNA synthesis was assayed by mea-
suring the incorporation of BrdU. In the absence of this mAb-i,
the amount of cell surface Necl-5 and the degree of DNA syn-
thesis of NIH3T3 cells cultured at the higher density decreased
in a roughly parallel manner (Fig. 5, A [b] and B [a, c, and e]).
The decreases of these parameters were inhibited by the
mAb-i (Fig. 5, A [b] and B [b, d, and e]). In the nectin-3
knockdown cells, the cell density–dependent decreases of cell
movement and DNA synthesis were similarly inhibited (Fig. 6,
A and B). The levels of this inhibition were roughly similar to
Figure 4. Clathrin-dependent endocytosis of Necl-5. (A) Inhibition of down-
regulation of Necl-5 by a DN mutant of epsin, Eps15, or dynamin, but not
by a DN mutant of caveolin. Immunofluorescence images of the cells trans-
fected with various DN mutants. The cells were transfected with myc-epsin
DN mutant (a), EGFP-Eps15 DN mutant (b), HA-dynamin DN mutant (c), or
EGFP-caveolin DN mutant (d); cultured at the higher density; and double or
triple stained with various combinations of the anti–Necl-5 mAb-i, the anti-
myc mAb, the anti-HA mAb, and the anti–nectin-3 pAb. Asterisks show the
transfected cells. Bars, 10  m. (B) Assembly of clathrin heavy chain at the
cytoplasmic region of Necl-5, which interacts with Nef-3. NIH3T3 cells
were cultured at the lower density and then cultured in the presence or ab-
sence of Nef-3– or IgG-coated beads for 1 h. The cells were double stained
with the anti–Necl-5 mAb-i and the anticlathrin heavy chain mAb. (a) In the
presence of the Nef-3–coated beads; (b) in the presence of the IgG-coated
beads; (c) in the absence of the beads. Asterisks, the positions of the beads;
insets, magnified images of the boxed areas. Bars, 10  m. The results
shown are representative of three independent experiments. 
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those of the inhibition of the cell density–dependent down-
regulation of cell surface Necl-5 (Fig. 2). In addition, when
the cells were starved for 24 h and cultured in the presence of
serum and the mAb-i, the growth rate did not markedly
change, but the cell density rose to slightly higher than that of
the cells cultured in the absence of the mAb-i after they be-
came confluent (Fig. 1 A, a, open blue squares). These results
indicate that the interaction of Necl-5 with nectin-3 causes the
down-regulation of Necl-5, which subsequently reduces cell
movement and proliferation.
We furthermore confirmed the inhibitory effects of the
down-regulation of Necl-5 on cell movement and proliferation
by knocking down Necl-5 using the siRNA method. Transfec-
tion of the siRNA vector against Necl-5 reduced the amount of
cell surface Necl-5 as estimated by FACS analysis (Fig. 7 A, a).
It also reduced the total amount of Necl-5 as estimated by
Western blotting and immunofluorescence microscopy (Fig.
7 A, b–c2). The total amount of Necl-5 decreased to 
 
 
 
20%.
Movement and DNA synthesis of the Necl-5 knockdown cells
decreased as compared with those of the control cells as esti-
mated by the methods just mentioned (Fig. 7, B and C). These
results indicate that the down-regulation of Necl-5 reduces cell
movement and proliferation.
 
Discussion
 
We have shown here that cell surface Necl-5 is down-regulated
in a cell density–dependent manner in cultured NIH3T3 cells. As
cell density increases, incidence of cell–cell contacts increases.
We previously showed that Necl-5 localizes at the leading edges
(Ikeda et al., 2004). Therefore, when moving cells collide,
Necl-5 may be one of the molecules that first interact with a mol-
ecule of another moving cell. At present, three molecules that
trans-interact with Necl-5 have been identified: nectin-3, CD226/
DNAM-1, and CD96/Tactile (Bottino et al., 2003; Ikeda et al.,
2003; Mueller and Wimmer, 2003; Fuchs et al., 2004). CD226
and CD96 are also Ig-like molecules that are exclusively ex-
pressed in blood cells, including NK cells and T cells (Bottino et
al., 2003; Fuchs et al., 2004). Thus, of these molecules, only nec-
tin-3 is expressed in NIH3T3 cells. Moreover, our series of stud-
ies has revealed that when moving cells collide, nectin first
forms cell–cell contacts where cadherin is recruited, resulting in
the formation of adherens junctions (Takai and Nakanishi, 2003;
Takai et al., 2003). Therefore, it is most likely that when moving
cells collide, Necl-5 first interacts with nectin-3, which then in-
duces the down-regulation of Necl-5. We have presented three
lines of evidence for this conclusion: (1) the anti–Necl-5 mAb-i,
which is able to inhibit the interaction of Necl-5 with nectin-3,
inhibits the cell density–dependent down-regulation of Necl-5;
(2) the knockdown of nectin-3 inhibits the cell density–dependent
down-regulation of Necl-5; and (3) Nef-3 induces the down-
regulation of Necl-5 of the cells that do not contact other cells.
These results do not exclude the possibility that Necl-5 interacts
with a still unidentified molecule in NIH3T3 cells in addition to
nectin-3 and induces the down-regulation of Necl-5, but the
present results indicate that nectin-3 is at least a major molecule
that interacts with Necl-5 upon cell–cell contacts and induces the
down-regulation of Necl-5 in NIH3T3 cells.
The cell–cell contact-induced down-regulation of Necl-5
from the cell surface might be the result of its endocytosis, re-
duction of de novo synthesis, or both. We have shown here that
the cell density–dependent down-regulation of Necl-5, at least
at the early stage, is mainly mediated by clathrin-dependent en-
docytosis. Therefore, the interaction of Necl-5 with nectin-3
down-regulates Necl-5 through clathrin-dependent endocyto-
sis. The detailed molecular mechanism of the endocytosis in-
duced by the interaction of Necl-5 with nectin-3 is not known,
but we have shown here that this interaction recruits the com-
ponents necessary for the clathrin-dependent endocytosis, in-
cluding clathrin heavy chain and adaptin 
 
 
 
, to the cytoplasmic
region of Necl-5, which interacts with nectin-3. Therefore, the
mechanism of endocytosis of Necl-5 is likely to be analogous
Figure 5. Cell density–dependent reduction of cell movement and DNA
synthesis by the down-regulation of Necl-5. (A) Measurement of cell move-
ment by Boyden chamber assay. (a) Quantification of migrated cells.
NIH3T3 cells were cultured at the lower or higher density in the presence
or absence of the anti–Necl-5 mAb-i for 24 h, replated in culture insert,
and cultured for 9 h. The migrated cells were counted. *, P   0.001. (b)
Reversion of the level of cell surface Necl-5. The cells were cultured at the
lower or higher density in the presence or absence of the anti–Necl-5
mAb-i, replated at the lower density, and cultured for 9 h. Biotinylated cell
surface Necl-5 was collected before (0 h) or after (9 h) replating and sub-
jected to SDS-PAGE (10% polyacrylamide gel), followed by Western blot-
ting with the anti–Necl-5 mAb-i. (B) Measurement of DNA synthesis by
BrdU incorporation. The cells were cultured at the lower or higher density
in the presence or absence of the anti–Necl-5 mAb-i for 24 h, incubated
with BrdU for 2 h, and then double stained with the anti-BrdU mAb and
DAPI. (a and c) In the absence of the anti–Necl-5 mAb-i; (b and d) in the
presence of the anti–Necl-5 mAb-i; (e) quantification of BrdU-positive cells.
Bars, 20  m. *, P   0.001. The results are the mean   SEM of the three
independent experiments. 
NECL-5, NECTIN-3, AND CONTACT INHIBITION • FUJITO ET AL.
 
171
 
to that of the endocytosis of cell surface receptors for hormones
and cytokines, which are soluble molecules and coendocytosed
with their respective membrane receptors upon their activation
by hormones and cytokines. When Nef-3 is used as a ligand for
Necl-5, it also serves as a soluble ligand for Necl-5 and is simi-
larly coendocytosed with Necl-5. In contrast, nectin-3 is a
transmembrane protein that trans-interacts with Necl-5 and is
resistant to coendocytosis with Necl-5. One possible mecha-
nism of the nectin-3–induced endocytosis of Necl-5 is that the
interaction of Necl-5 with nectin-3 causes the clustering of
Necl-5, where the components of the clathrin-dependent en-
docytosis assemble and eventually form coated pits, followed
by budding and pinching off of vesicles. In these processes,
Necl-5, which interacts with nectin-3, may be replaced by
nectin-1, resulting in the formation of free Necl-5, which is
finally endocytosed, because the affinity of nectin-3 for nectin-1
is 10-fold higher than that of nectin-3 for Necl-5 (Ikeda et al.,
2003). The interaction of nectin-3 with nectin-1 then induces
the recruitment of N-cadherin there, resulting in the formation
of adherens junctions. Another possible mechanism is that nec-
tin-3, which interacts with Necl-5, is cleaved at the extracellu-
lar region and that its extracellular fragment is coendocytosed
with Necl-5. Conversely, Necl-5, which interacts with nectin-3,
may be cleaved at the extracellular region, and its extracellular
fragment may be coendocytosed with nectin-3. However, the
former possibility is less likely because cell surface nectin-3
did not decrease in a cell density–dependent manner.
When the cells were treated with Nef-3, the spotlike in-
tracellular signal for Necl-5 increased and mostly colocalized
with the signal for Rab7, which is a late endosomal marker.
Figure 6. Inhibition of cell density–dependent
reduction of cell movement and DNA synthesis
by the knockdown of nectin-3. NIH3T3 cells
were transfected with the synthetic siRNA
against nectin-3 or the control synthetic siRNA
and cultured for 48 h. The knockdown of nec-
tin-3 inhibited the cell density–dependent down-
regulation of Necl-5 (see Fig. 2). (A) Measure-
ment of cell movement by Boyden chamber as-
say. The transfected cells were cultured at the
lower or higher density for 24 h, replated in
culture insert, and cultured for 9 h. The mi-
grated cells were counted. *, P   0.001. (B)
Measurement of DNA synthesis by BrdU incor-
poration. The transfected cells were cultured at
the lower or higher density for 24 h, incubated
with BrdU for 2 h, and then double stained with
the anti-BrdU mAb and DAPI. (a and c) Control;
(b and d) nectin-3 siRNA; (e) quantification of
BrdU-positive cells. Bars, 20  m. *, P   0.001.
The results are the mean   SEM of the three
independent experiments.
Figure 7. Reduction of cell movement and
DNA synthesis by the knockdown of Necl-5.
NIH3T3 cells were transfected either with the
siRNA vector against Necl-5 and the pEGFP-
tub vector or with the control siRNA vector
and the pEGFP-tub vector and cultured at the
lower density for 48 h. The transfection effi-
ciency was  20%. (A) Confirmation of the
knockdown of Necl-5. (a) FACS analysis. The
cells were stained with the anti–Necl-5 mAb-i
and the EGFP-tub–positive cells were moni-
tored. (b) Western blotting. The EGFP-tub–
positive cells were sorted by FACS and then
the lysate of the sorted cells was subjected to
SDS-PAGE (10% polyacrylamide gel), fol-
lowed by Western blotting with the anti–Necl-5
mAb-i. (c) Immunofluorescence images. The
cells were single stained with the anti–Necl-5
mAb-i. (c1) Necl-5; (c2) Necl-5 and EGFP-tub.
Asterisks show the Necl-5 knockdown cells.
Bar, 10  m. (B) Measurement of cell move-
ment by Boyden chamber assay. The trans-
fected cells ( 20% transfection efficiency) were cultured at the lower density, directly replated in culture insert, and cultured for 9 h. The EGFP-tub–positive
migrated cells were counted. The number of control EGFP-tub–positive migrated cells was consistent with that of control migrated cells precultured at lower
density in Fig. 5 A (a) and Fig. 6 A, considering the transfection efficiency. *, P   0.001. (C) Measurement of DNA synthesis by BrdU incorporation. The
transfected cells ( 20% transfection efficiency) were directly cultured at the lower density for 18 h and incubated with BrdU for 2 h. The cells were double
stained with the anti-BrdU mAb and DAPI. The EGFP-tub–positive cells were measured. (a) Control; (b) Necl-5 siRNA; (c) quantification of BrdU-positive
cells. Bars, 20  m. *, P   0.001. The results shown in A are representative of three independent experiments, and the results shown in B and C are the
mean   SEM of the three independent experiments. 
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In contrast, this spotlike signal for Necl-5 was not observed in
the cells cultured at the higher cell density in the absence of
Nef-3, although the cell surface signal for Necl-5 markedly de-
creased. The exact reason for this apparent discrepancy is not
known, but one possible explanation is that Necl-5 was en-
docytosed and transported to the late endosome in the cells cul-
tured at the higher density in the absence of Nef-3 but its
amount in the late endosome was too low to be detected. The
other possible explanation is that when the cells were treated
with Nef-3, Necl-5 was coendocytosed with Nef-3 and the
Necl-5–Nef-3 complex was delivered to the late endosome and
was not further transported to the lysosome, where the proteins
might be degraded, whereas Necl-5 free of nectin-3 was trans-
ported to the lysosome, where it was degraded in the cells cul-
tured at the higher density in the absence of Nef-3.
We previously showed that Necl-5 has a potency to en-
hance cell movement and proliferation induced by growth fac-
tors such as PDGF and FGF (Ikeda et al., 2004; Kakunaga et al.,
2004). Consistent with this finding, our current results show that
the cell–cell contact-induced down-regulation of Necl-5 causes
reduction of cell movement and proliferation. The inhibition of
this down-regulation by the anti–Necl-5 mAb-i or the knock-
down of nectin-3 blocks the reduction of cell movement and
proliferation. The artificial knockdown of Necl-5 by the siRNA
method similarly reduces cell movement and proliferation.
Therefore, it is likely that the interaction of Necl-5 with nectin-3
causes the down-regulation of Necl-5, which then reduces cell
movement and proliferation. As cultured cells become conflu-
ent, they form cell–cell adhesion, gradually reducing and then fi-
nally stopping movement and proliferation (Abercrombie and
Heaysman, 1953; Fisher and Yeh, 1967). This phenomenon has
for a long time been known as contact inhibition of cell move-
ment and proliferation, and several mechanisms have been re-
ported. For instance, the vascular endothelial cadherin–
 
 
 
-cate-
nin complex inhibits the VEGF signaling for endothelial cell
proliferation (Grazia Lampugnani et al., 2003); the E-cadherin–
mediated cell–cell adhesion down-regulates extracellular reg-
ulated protein kinase signaling through the phosphoinositide
3-kinase–Akt pathway for cell proliferation (Laprise et al.,
2004); the neurofibromatosis-2 gene product, merlin, and a trans-
membrane hyaluronic acid receptor, CD44, form a molecular
switch that specifies cell growth arrest or proliferation (Morrison
et al., 2001); and the effector of Rac/Cdc42, PAK1, and the PAK-
interacting Rac-guanine nucleotide exchange factor, PIX, regu-
late contact inhibition during epithelial wound healing (Zegers et
al., 2003). The present results that the cell–cell contact-induced
interaction of Necl-5 with nectin-3 and the subsequent endocyto-
sis-mediated down-regulation of Necl-5 and reduction of cell
movement and proliferation suggest that this mechanism is an ad-
ditional mechanism for the contact inhibition of cell movement
and proliferation. All the experiments shown here were per-
formed by use of NIH3T3 cells, but essentially the same results
were obtained for MEFs (see the online supplemental material
and Figs. S1–S5, available at http://www.jcb.org/cgi/content/full/
jcb.200501090/DC1). Therefore, the down-regulation of Necl-5
induced by its interaction with nectin-3 upon cell–cell contacts is
observed not only in NIH3T3 cells but also in MEFs.
 
Materials and methods
 
Cell culture
 
NIH3T3 cells were obtained from American Type Culture Collection. NIH3T3
cells were maintained in DME supplemented with 10% calf serum. For cul-
tures at the lower or higher density, NIH3T3 cells were plated at a density of
5 
 
 
 
 10
 
3
 
 or 4 
 
 
 
 10
 
4
 
 cells per cm
 
2
 
, respectively, and cultured for 24 h.
For DNA transfection, Lipofectamine 2000 reagent (Invitrogen) was used.
 
Antibodies (Abs) and reagents
 
A rat IgG2a
 
 
 
 mAb against the extracellular region of Necl-5 (1A8-8,
mAb-i) was prepared as described previously (Ikeda et al., 2003). A rab-
bit polyclonal Ab against the extracellular region of Necl-5 was used for
Western blotting. Rabbit anti–nectin-1 pAb, rat anti–nectin-3 mAb, and
rabbit anti–nectin-3
 
 
 
 pAb were prepared as described previously (Satoh-
Horikawa et al., 2000; Sakisaka et al., 2001). Hybridoma cells (9E10)
expressing a mouse anti-myc mAb were purchased from American Type
Culture Collection. A mouse anti–N-cadherin mAb, mouse anticlathrin
heavy chain mAb, and mouse adaptin 
 
 
 
 mAb were purchased from BD
Biosciences. A rabbit anti–N-cadherin pAb was purchased from Takara.
A mouse antiactin mAb was purchased from Chemicon. A mouse anti-HA
mAb was purchased from Babco. A goat anti-Rab7 pAb was purchased
from Santa Cruz Biotechnology, Inc. HRP-conjugated and fluorophore-con-
jugated secondary Abs were purchased from GE Healthcare, Chemicon,
Jackson ImmunoResearch Laboratories, and ICN Biomedicals. DAPI was
purchased from Nacalai Tesque. Nef-1 or -3 was prepared as described
previously (Honda et al., 2003) and cross-linked by a rabbit anti–human
IgG Fc pAb (Jackson ImmunoResearch Laboratories) before use.
pEFBOS-myc-epsin epsin NH
 
2
 
-terminal homology was supplied by A.
Kikuchi (Hiroshima University, Hiroshima, Japan); pEGFP-Eps15 DIII by A.
Benmerah (Cochin Institute, Paris, France); pCIneo-HA-dynamin1 K44A by
S.L. Schmid (The Scripps Research Institute, La Jolla, California); pEGFP-DGV-
caveolin by T. Fujimoto (Nagoya University, Nagoya, Japan); and pBS-H1
vector by H. Shibuya (Tokyo Medical and Dental University, Tokyo, Japan).
 
Immunofluorescence microscopy
 
The cells were fixed with 1% formaldehyde in PBS for 15 min and perme-
abilized with 100% methanol. Alternatively, the cells were fixed with ace-
tone/methanol (1:1) for 1 min at 
 
 
 
20
 
 
 
C. The cells, which were precultured
with the anti–Necl-5 mAb-i, were washed with a stripping buffer (0.2 M
acetic acid and 0.5 M NaCl) before fixation. For blocking, the samples
were incubated with 1% BSA in PBS and then with 20% BlockAce (Dainip-
pon Seiyaku) in PBS. The samples were stained with the various combina-
tions of the primary Abs and then with appropriate fluorophore-conjugated
secondary Abs. The samples were analyzed using a confocal laser scan-
ning microscope (Radiance 2000 or 2100; Bio-Rad Laboratories).
 
siRNA experiments
 
For the knockdown of nectin-3, double-stranded 25-nt RNA duplex, stealth
RNA interference, to nectin-3 (5
 
 
 
-UGAUCAAUGUGCUGUUCAA-3
 
 
 
) and
control stealth RNA interference duplex were purchased from Invitrogen.
Duplexes were transfected using Lipofectamine 2000 reagent according
to the manufacturer’s protocol. The transfection efficiency was monitored
using FITC-labeled RNA oligo (Invitrogen). For the knockdown of Necl-5,
the pBS-H1 vector containing H1 promoter was used for the expression of
siRNA. To generate a vector for knockdown of Necl-5 (pBS-H1-Necl-5), a
specific insert for Necl-5 was subcloned into pBS-H1. The insert was used
as follows: mouse Necl-5 gene-specific insert was a 19-nt sequence corre-
sponding to nt 767–785 (5
 
 
 
-GGTATGTTGGCCTCACTAA-3
 
 
 
) of mouse
Necl-5 cDNA, which was separated by a 9-nt noncomplementary spacer
(5
 
 
 
-TTCAAGAGA-3
 
 
 
) from the reverse complement of the same 19-nt se-
quence. A pBS-H1 control vector had an insert including a 19-nt sequence
(luciferase; 5
 
 
 
-CGTACGCGGAATACTTCGA-3
 
 
 
) with no significant homol-
ogy to any mammalian gene sequence. The cells were cotransfected with
the pBS-H1 vector and the pEGFP-tub vector (CLONTECH Laboratories,
Inc.) using Lipofectamine 2000 reagent. The EGFP-tub–positive cells were
monitored as a marker of the cotransfection.
 
Boyden chamber assay
 
The Boyden chamber assay was performed as described previously (Ikeda
et al., 2004), with some modifications. NIH3T3 cells were seeded at a
density of 10
 
4
 
 cells per insert. The cells were incubated at 37
 
 
 
C for 9 h in
the presence of 10% serum. The migrated cells, which were stained with
crystal violet or expressed EGFP-tub, were counted by phase contrast or
fluorescence microscopic examination, respectively. 
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Other procedures
 
Cell growth assay and FACS analysis were performed as described previ-
ously (Kakunaga et al., 2004). Quantification of cell surface proteins and
endocytosed Necl-5 by the biotinylation method were performed as de-
scribed previously (Le et al., 1999). The endocytosis assay was performed
at 18
 
 
 
C to inhibit recycling. Real-time RT-PCR was performed as described
previously (Hirota et al., 2005). The levels of Necl-5 mRNA were deter-
mined as the absolute value to total RNA. Bead-cell adhesion assay using
Nef-3–coated latex beads was performed as described previously (Honda
et al., 2003). The DNA synthesis assay was performed by using a BrdU la-
beling and detection kit I (Roche) according to the manufacturer’s protocol.
 
Online supplemental material
 
Online supplemental text describes that the down-regulation of Necl-5 in-
duced by its interaction with nectin-3 upon cell–cell contacts is observed in
MEFs. It also describes additional materials and methods for the experi-
ments using MEFs. Fig. S1 shows that Necl-5 is down-regulated in a cell
density–dependent manner in MEFs. Figs. S2 and S3 show that the cell
density–dependent down-regulation of Necl-5 is induced by its interaction
with nectin-3 in MEFs. Fig. S4 shows that Necl-5 is down-regulated by the
clathrin-dependent endocytosis in MEFs. Fig. S5 shows that the down-reg-
ulation of Necl-5 reduces cell movement and proliferation in MEFs. Online
supplemental material is available at http://www.jcb.org/cgi/content/
full/jcb.200501090/DC1.
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